BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//BioCT - ECPv6.17.3//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:BioCT
X-ORIGINAL-URL:https://bioct.org
X-WR-CALDESC:Events for BioCT
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20250309T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20251102T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20260308T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20261101T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20270314T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20271107T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20260910T170000
DTEND;TZID=America/New_York:20260910T190000
DTSTAMP:20260902T133751Z
CREATED:20260416T162111Z
LAST-MODIFIED:20260902T133751Z
UID:10003046-1789059600-1789066800@bioct.org
SUMMARY:BioCT’s Annual Mixer + Special Edition Collaborative Connecticut
DESCRIPTION:This is one of BioCT’s most highly attended events\, bringing together 400+ industry colleagues and state officials for a casual evening by the picturesque Branford waterfront.  Open to everyone in the life sciences\, come enjoy an evening of networking\, craft beer and good company. ​Co-hosted with Yale Ventures. \nThis year we are pleased to spotlight and partner with The Epilepsy Foundation of Connecticut and The Tommy Fund for Childhood Cancer. \nThe Epilepsy Foundation of Connecticut (EFCT) is the state’s only affiliate of the National Epilepsy Foundation\, providing education\, advocacy\, and direct support to the approximately 40\,000 Connecticut residents living with epilepsy. EFCT offers programs ranging from seizure first aid training to community camps and statewide advocacy\, helping individuals and families navigate epilepsy with confidence and connection. \nSince 1953\, the Tommy Fund has supported children battling cancer and their families through treatment and recovery. From funding care at Yale New Haven Children’s Hospital to providing financial assistance and survivorship support through the HEROS program at Yale\, their work makes a real difference when it’s needed most. \nTHIS EVENT PROUDLY SPONSORED BY: \nPremier Sponsor:   \nTable Sponsors: BioLabs New Haven\, CBIZ\, CFGI\, Fisher Scientific\, J.P. Morgan\, Paw Haven\, Precision Biotools\, SCSU Innovation Hub\, SCSU College of Arts and Sciences\, Tweed New Haven\, Yale Ventures \nFor details on sponsorship\, please click here and contact Kelley Gipson at kgipson@bioct.org to get started.
URL:https://bioct.org/event/biocts-annual-mixer-special-edition-collaborative-connecticut-2/
LOCATION:New England Brewing Company\, 5 Indian Neck Avenue\, Branford\, CT\, 06405
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20260520T113000
DTEND;TZID=America/New_York:20260520T133000
DTSTAMP:20260519T122737Z
CREATED:20260420T160644Z
LAST-MODIFIED:20260519T122737Z
UID:10003047-1779276600-1779283800@bioct.org
SUMMARY:BioCT Facilities & Lab Operations Roundtable: Strategic Sustainability: Cost-Conscious Innovation in Labs
DESCRIPTION:Back by popular demand\, this session will explore how Impact Laboratories – the certification and verification arm of My Green Lab – alongside leading Connecticut life sciences companies\, is advancing environmentally responsible research while driving operational efficiency and cost savings. \nModerators: \n\nDemet Aybar\, Founder & CEO US Lab Partners\nMike Juron\, Vice President\, Americas\, SciSure\n\nPanelists: \n\nHalie Beckert\, Associate Director\, EH&S and Site Operations\, Arvinas\nAmanda Dioszeghy\, Sustainability Program Manager\, The Jackson Laboratory\nCara Hill\, Science + Technology Industry Specialist and Sustainability Liaison\, Whiting-Turner Contracting Corp\nKris Kennedy\, Executive Director\, Facilities\, EHS & Site Engineering\, MannKind Corporation\nAndre Lowe\, Head of Site Operations\, ViiV Healthcare\nKayla Stocking\, Market Development Representative\, Impact Laboratories\n\nLunch will be provided. \nThank you to our generous sponsors: \n                 \n  \nLearn more about sponsorship opportunities here.
URL:https://bioct.org/event/bioct-facilities-lab-operations-roundtable-strategic-sustainability-cost-conscious-innovation-in-labs/
LOCATION:101 College St\, 101 College St\, New Haven\, CT\, 06510
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20260427T150000
DTEND;TZID=America/New_York:20260427T170000
DTSTAMP:20260420T185451Z
CREATED:20260403T135652Z
LAST-MODIFIED:20260420T185451Z
UID:10003032-1777302000-1777309200@bioct.org
SUMMARY:Life Science in Connecticut: Trends\, Talent\, and the Road Ahead
DESCRIPTION:Join us for an insightful panel bringing together industry leaders to examine the forces shaping Connecticut’s life sciences sector\, including innovation trends\, market dynamics\, and emerging challenges. Panelists will explore what these developments mean for the future workforce—highlighting in‑demand skills\, career pathways\, and opportunities for students and faculty. \nThis is also a unique opportunity to network with industry leaders\, academic leaders\, and life science students. \nPlease click here for parking directions. \nAgenda \nWelcome & Introductions: \n\nMatt Caporale\, Executive Director\, Career Development\, University of New Haven\nJodie Gillon\, President & CEO\, BioCT: Overview of BioCT\nPaul Lavoie\, Vice President of Innovation and Applied Technology: Overview of University of New Haven\n\nPanel Discussion  \n\nState of the Biotech Sector\nIndustry Structure: Key Issues and Opportunities\nWorkforce Development: Pathways\, Technical Skills\, & Soft Skills\nOpportunities & Challenges\n\n Audience Q&A  \nClosing  \n— \nModerator: \n \nMatt Caporale\, Executive Director\, University of New Haven Career Development Center \nAt the University of New Haven\, Matt leads the career development unit\, including setting departmental mission\, vision\, and strategy for a centralized office that builds student career and application readiness into talent acquisition pipelines for industry. Matt’s approach blends traditional career development with modern staffing agency services to deliver curated candidates to industry partners\, quickly. This vision has led to annual growth in student engagement\, student outcomes\, collaborative programs\, and a #17 ranking from the Princeton Reviews for Top Career Services offices in the nation. Matt holds a Masters of Arts in History from the University of North Carolina at Charlotte and a Bachelor’s Degree in History from the State University of New York at Brockport.  \n  \nPanelists: \n   \nJenna DiRito\, PhD\, COO & Co-founder\, Revalia Bio \nJenna is a world-leading expert in human organ research operations. During her training she has perfused hundreds of kidneys\, livers\, and lungs to develop a better understanding of how to best preserve\, assess and repair marginal organs that were declined for transplantation.  She received her PhD in Surgery from the University of Cambridge where she worked with the pioneers of normothermic kidney perfusion after earning her B.S. from Yale University. Dr. DiRito completed her postdoctoral training at Yale School of Medicine where she established and led a diverse team of organ perfusionists with the capacity to execute 100+ multi-day liver perfusions each year.  She received multiple honors including the 2021 Roy Calne Award for best manuscript in transplant science\, the 2022 American Society of Transplantation Recovery and Preservation Rising Star Award\, the 2022 and 2023 Cutting Edge of Transplantation Visionaries Awards\, and was recently recognized on the 2025 Forbes 30 Under 30: Science list. \n  \n \nJodie Gillon\, President & CEO\, BioCT \nJodie brings over 25 years of experience in large pharma & biotech having started her career in advocacy and hospitals\, in the US and abroad. With vast expertise leading key functions\, she is sought after as an advisor to Incubators and Innovation Centers\, and as a consultant for biotech\, AI\, RWE\, digital health\, and non profit organizations. Jodie most recently served as the SVP of Corporate Affairs and Patient Advocacy at Peptilogics. She previously served as the Chief Patient Officer and Head of Clinical Affairs Affairs at Abeona Therapeutics. At Pfizer\, Jodie was the Global Medical Lead\, Patient Engagement\, for the Rare Diseases Business Unit and the Director\, Medical Communications.  Prior to Pfizer\, Jodie was the Head of Patient Advocacy and Professional Affairs with Achillion Pharmaceuticals. Previously she served as the Head of the Chief Medical Office (CMO) of AstraZeneca and held additional roles as the Global Communications lead at Novartis\, Director of Medical Education for Oridion Medical and as a Health Economist with the Israeli Center for Disease Control and Ministry of Health. She holds a Master’s of Public Health with a dual degree in Health Economics and Epidemiology from Hebrew University in Jerusalem and a BSFS from Georgetown’s School of Foreign Service. \n  \n \nAndrew Leverton\, Campus Recruiter\, Engineering\, Medtronic \nAndrew (UNH Alum – MA IO Psychology ’17) is a seasoned HR/Talent Acquisition professional bringing a decade of expertise in the medical device\, aerospace\, and retail industries. Over the last 8 years with Medtronic\, Andrew has lead strategic nationwide hiring initiatives for Medtronic focused on based medical sales/clinical professionals\, high impact project work\, and is a local leader in the Medtronic Young Professionals ERG. Currently he leads Campus Recruitment for the Software Engineering functions\, coordinates all intern programming for the North Haven\, CT site\, and maintains relationships with key partner universities in the Northeast. \n  \n \nChad Smutney\, BSME\, Vice President Technology\, MannKind \nChad joined MannKind in 2006 and immediately formed a technology development team chartered with advancing the pulmonary delivery of insulin using dry powders that feature Technosphere® technology. His work at MannKind has resulted in the DreamBoat® and Cricket® inhaler systems as well as several ancillary technologies such as BluHale® designed to ease user onboarding of dry powder products. Over the years\, two FDA regulatory approvals for orally inhaled dry powders were achieved\, one for Afrezza used in treatment of diabetes and one for Tyvaso DPI used in treatment of pulmonary arterial hypertension and pulmonary hypertension associated with interstitial lung disease. During the journey\, Chad spearheaded many expansions involving facilities\, infrastructure\, and manufacturing capacity in MannKind’s Danbury plant. Most recently\, Chad has focused on portfolio expansion at MannKind where several new products candidates are under development. \n  \n \nJackson Weisman\, Business Associate\, Business Development\, Advance CT \nJackson serves as a Business Associate on the Business Development team at AdvanceCT\, Connecticut’s nonprofit economic development organization. He supports the recruitment of companies nationally and internationally\, helping businesses expand in and relocate to Connecticut through access to talent\, funding\, facilities\, state partnerships\, and academic connections. Jackson focuses on aligning company needs with Connecticut’s strategic advantages across the state’s key sectors. A native of Fairfield\, Connecticut\, Jackson graduated from Trinity College.
URL:https://bioct.org/event/biotech-in-connecticut-trends-talent-and-the-road-ahead/
LOCATION:University of New Haven\, 300 Boston Post Road\, West Haven\, CT\, 06516
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20260205T163000
DTEND;TZID=America/New_York:20260205T180000
DTSTAMP:20251216T201428Z
CREATED:20251216T201113Z
LAST-MODIFIED:20251216T201428Z
UID:10002958-1770309000-1770314400@bioct.org
SUMMARY:Book Launch: A Conversation with Dr. Yin Ho\, Author of Rushing Headlong: Health IT's Legacy and the Road to Responsible AI
DESCRIPTION:Join us for a conversation with Dr. Yin Ho\, MD\, MBA\, the author of Rushing Headlong: Health IT’s Legacy and The Road to Responsible AI\, which traces the journey from early health IT hopes to the rise of generative AI in medicine. \n​Blending personal stories with deep industry experience\, she dissects how both public and private leaders have let key opportunities slip away\, leaving behind a healthcare system that is often disjointed and frustrating for patients\, clinicians\, and researchers alike. \n​Dr. Ho does not pull punches as she guides the reader through the damage done by regulatory capture and how generative AI can help transform mountains of medical data into real progress. \n​Clear-eyed and unapologetic\, this book exposes how every healthcare stakeholder in the system shares responsibility for our current predicament- and why fixing it demands intention\, collaboration\, and courage from all of us. \nAuthor: \n \n\n\n\n\nYin Ho\, M.D.\, M.B.A. \n\n\n\n\n\n\n\n\nA serial entrepreneur and visionary executive in the Health IT and clinical research space\, Dr. Ho has been founding\, building\, and leading Health IT companies and initiatives for over 25 years. \nMost recently\, Dr. Ho was the interim CEO at Veradigm (MDRX) where she led the strategic acquisition of a generative AI company\, Science IO. As the first electronic health record firm to have its own proprietary LLM capabilities (in the form of small language models) in-house\, she charted a direction to improve the quality of data collection and data abstraction for both clinical care and research. A longtime strategic thinker\, Dr. Ho also founded and led Context Matters Inc. — the first data analytics software company focused on global health technology assessments and linking health economics to clinical trial outcomes. Today\, Context Matters is part of Clarivate Analytics (CLVT). \nDr. Ho led eHealth at Pfizer (PFE) in the early years of Health IT\, and served as the Chief Product and Strategy Officer for Aetion in the first years of real world evidence. She was also the VP of Product and Corporate Strategy at Medidata\, and part of the executive team who led the company through its IPO. \nOriginally trained as an emergency medicine physician at Yale\, Dr. Ho became excited about the potential of eHealth and changed careers quickly by earning an MBA from Harvard just as eHealth/Health IT was emerging. In fact\, to help push the Health IT ecosystem along\, she co-founded New York City Health Business Leaders (NYCHBL) — now Digital Health New York (DHNY) — to propel NYC into the healthcare innovation juggernaut it is today. \nDr. Ho is currently on the Board of Directors at Segmed (an AI-enabled radiology data aggregator for real world evidence) and serves as an advisor to Lighten AI (a clinical abstraction AI company) and Novellia (an AI-enabled personal health data company). \nDr. Ho earned her B.A. from Brown University\, her M.D. from Yale University School of Medicine\, and her M.B.A. from Harvard Business School.
URL:https://bioct.org/event/book-launch-a-conversation-with-dr-yin-ho-author-of-rushing-headlong-health-its-legacy-and-the-road-to-responsible-ai/
LOCATION:BioLabs\, 101 College St\, New Haven\, CT\, 06511
END:VEVENT
END:VCALENDAR